Centocor Ortho Biotech Articles
AVEO Pharma licenses RON-targeted antibodies to Johnson & Johnson unit for up to $555 million
1 June 2011
Abbott prevails as US Court of Appeals overturns $1.8 billion patent verdict for J&J unit
24 February 2011
Abbott/Eisai's Humira emerges as market leader in psoriatic arthritis, garnering sales of over $500 million in 2009
5 November 2010
Rheumatoid arthritis patient share of Actemra projected to exceed that of Cimzia and Simponi among US Medicare population
4 November 2010
Showing 1-8 of 8 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
